Literature DB >> 17225181

Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.

Julie P Taylor1, Mary M Hulihan, Jennifer M Kachergus, Heather L Melrose, Sarah J Lincoln, Kelly M Hinkle, Jeremy T Stone, Owen A Ross, Robert Hauser, Jan Aasly, Thomas Gasser, Haydeh Payami, Zbigniew K Wszolek, Matthew J Farrer.   

Abstract

Leucine-rich repeat kinase 1 gene (LRRK1) on chromosome 15q26.3 is a paralog of LRRK2 in which multiple substitutions were recently linked to Parkinson's disease. We have examined the exon-intron structure of the gene and the expressed mRNA sequence in brain. LRRK1 sequencing analysis in 95 probands from families with autosomal dominant Parkinson's disease identified 23 variants, 14 of which are novel, with four resulting in non-synonymous amino acid substitutions. These four substitutions are rare and do not clearly segregate with disease within our families or associate with sporadic Parkinson's disease in a US case-control series. Subsequent sequencing of exon 26 encoding the kinase activation segment in an additional 360 probands identified one further synonymous variant, suggesting that LRRK1 variants are not a frequent cause of Parkinson's disease. The relative absence of substitutions within LRRK1 highlights a greater conservation of sequence than observed for LRRK2. Comparison of evolutionary interspecies sequences of LRRK1 and LRRK2 suggests they diverged from a common founder gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17225181     DOI: 10.1007/s10048-006-0075-8

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  26 in total

1.  Thirty-plus functional families from a single motif.

Authors:  L Yu; C Gaitatzes; E Neer; T F Smith
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

4.  Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Authors:  Daniela Berg; Katherine J Schweitzer; Petra Leitner; Alexander Zimprich; Peter Lichtner; Petra Belcredi; Theresa Brüssel; Claudia Schulte; Sylvia Maass; Thomas Nägele; Zbigniew K Wszolek; Thomas Gasser
Journal:  Brain       Date:  2005-12       Impact factor: 13.501

5.  The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.

Authors:  A M Schlitter; D Woitalla; T Mueller; J T Epplen; G Dekomien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07       Impact factor: 10.154

6.  Familial parkinsonism, dementia, and Lewy body disease: study of family G.

Authors:  M A Denson; Z K Wszolek; R F Pfeiffer; E K Wszolek; T M Paschall; R D McComb
Journal:  Ann Neurol       Date:  1997-10       Impact factor: 10.422

Review 7.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

Review 8.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

Review 9.  Interaction of Gbetagamma with RACK1 and other WD40 repeat proteins.

Authors:  Songhai Chen; Bryan D Spiegelberg; Fang Lin; Edward J Dell; Heidi E Hamm
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  18 in total

Review 1.  LRRK2 pathobiology in Parkinson's disease.

Authors:  Ian Martin; Jungwoo Wren Kim; Valina L Dawson; Ted M Dawson
Journal:  J Neurochem       Date:  2014-10-10       Impact factor: 5.372

2.  Leucine-Rich Repeat Kinase 1 Regulates Autophagy through Turning On TBC1D2-Dependent Rab7 Inactivation.

Authors:  Toshihiko Toyofuku; Keiko Morimoto; Shigemi Sasawatari; Atsushi Kumanogoh
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

3.  Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease.

Authors:  Justus C Dachsel; Kenya Nishioka; Carles Vilariño-Güell; Sarah J Lincoln; Alexandra I Soto-Ortolaza; Jennifer Kachergus; Kelly M Hinkle; Michael G Heckman; Barbara Jasinska-Myga; Julie P Taylor; Dennis W Dickson; Rachel A Gibson; Faycal Hentati; Owen A Ross; Matthew J Farrer
Journal:  Mech Ageing Dev       Date:  2010-02-06       Impact factor: 5.432

4.  Ancient origin of the Parkinson disease gene LRRK2.

Authors:  Ignacio Marín
Journal:  J Mol Evol       Date:  2008-06-04       Impact factor: 2.395

5.  Update on the functional biology of Lrrk2.

Authors:  Heather Melrose
Journal:  Future Neurol       Date:  2008

Review 6.  Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease.

Authors:  Saskia Biskup; Andrew B West
Journal:  Biochim Biophys Acta       Date:  2008-10-10

Review 7.  The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

Authors:  Rebekah G Langston; Iakov N Rudenko; Mark R Cookson
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

8.  Multiple genes on chromosome 7 regulate dopaminergic amacrine cell number in the mouse retina.

Authors:  Irene E Whitney; Mary A Raven; Daniel C Ciobanu; Robert W Williams; Benjamin E Reese
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-24       Impact factor: 4.799

9.  The WD40 domain is required for LRRK2 neurotoxicity.

Authors:  Nathan D Jorgensen; Yong Peng; Cherry C-Y Ho; Hardy J Rideout; Donald Petrey; Peng Liu; William T Dauer
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways.

Authors:  Lauran Reyniers; Maria Grazia Del Giudice; Laura Civiero; Elisa Belluzzi; Evy Lobbestael; Alexandra Beilina; Giorgio Arrigoni; Rita Derua; Etienne Waelkens; Yan Li; Claudia Crosio; Ciro Iaccarino; Mark R Cookson; Veerle Baekelandt; Elisa Greggio; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2014-07-14       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.